US judge orders Apotex to pay Sanofi $442M damages in Plavix case
This article was originally published in Scrip
Executive Summary
A federal judge has ordered Apotex to pay $442.2 million plus interest as "economic damages" for the company's brief launch of an infringing version of Sanofi-Aventis's blockbuster drug, Plavix (clopidogrel), in 2006.